HealthTech News

Regulatory Trends in AI-enabled SaMDs

FDA authorisations of AI-enabled software as medical devices (SaMDs) have increased significantly. Over 50% of FDA authorisations have occurred since 2022 with the majority (76%)…


GLP-1s’ Challenge to Pharmacovigilance

The international popularity of GLP-1 agonists for weight loss has presented an unforeseen operational challenge for pharma as companies try to keep track of emerging…





Hot Topics at a Hot BSG Live’26

Medilogik was again at the British Society of Gastroenterology conference in June. EMS Product Owner Thomas Wareing reflects on five ‘hot topics’ from the event…






HealthTech Thought Leadership

GLP-1s’ Challenge to Pharmacovigilance

The international popularity of GLP-1 agonists for weight loss has presented an unforeseen operational challenge for pharma as companies try to keep track of emerging…






Health Technology Insight

Regulatory Trends in AI-enabled SaMDs

FDA authorisations of AI-enabled software as medical devices (SaMDs) have increased significantly. Over 50% of FDA authorisations have occurred since 2022 with the majority (76%)…